Effect of growth hormone on the immune function of dendritic cells

Chinese Medical Journal

Volumn 123, Issue 8, 2010, Pages 1078-1083

  Liu, Qiu Liang ^a   Wang, Yi Sheng ^a   Wang, Jia Xiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Dendritic cells; Growth hormone; Immune; Pegvisomant

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; PEGVISOMANT; T6 ANTIGEN;

ARTICLE; AUTOLOGOUS MIXED LYMPHOCYTE REACTION; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE INDUCTION; GROWTH HORMONE RELEASE; IMMUNOPHENOTYPING; MONONUCLEAR CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD; ANTIGENS, CD80; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH HORMONE; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS;

EID: 77951217545     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.08.019     Document Type: Article

References (30)

1. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, et al. Dendritic cell subsets in health and disease. Immunol Rev 2007; 10: 118-142.
2. Andrews DM, Maraskovsky E, Smyth MJ. Cancer vaccines for established cancer: how to make them better? Immunol Rev 2008; 4: 242-255.
3. Royer PJ, Bougras G, Ebstein F, Leveque L, Tanguy-Royer S, Simon T, et al. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy. Exp Hematol 2008; 3: 329-339.
4. Sousa-Canavez JM, Canavez FC, Leite KR, Camara-Lopes LH. Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: A promising approach for the treatment of prostate cancer. Genet Vaccines Ther 2008; 6: 2.
5. Shan BE, Pan XM, Zhao LM, Liu LH, Wang XR, Zhang C. Icariin promotes differentiation and maturation of cord blood derived dendritic cells. Chin J Cancer Biother (Chin) 2009; 4: 325-330.
6. Jiang XW, Xu M. Recombinant E.coli LLO/WT1 induces the maturation of dendritic cell and promotes specific anti-tumor immunity. J Fourth Mil Med Univ (Chin) 2009; 19: 1887-1890.
7. He XK, Wu XL, He XJ, Li Bo, Hu YX. Dexamethasone impairs the differentiation and maturation of murine dendritic cells by Toll-like receptor 4-nuclear factor-κB pathway. Chin Med J 2010; 3: 344-350.
8. Pilon-Thomas S, Li W, Briggs JJ, Djeu J, Mulé JJ, Riker AI. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model. J Immunother 2006; 4: 381-387.
9. + dendritic cells. Chin Med J 2009; 122: 344-348
10. Wang JX, Liu GH, Fan YZ, Liu QL, Zhou J, Zhang DY, et al. Effects of CTL on hepatoma cell line SMMC-7721 induced by different subsets of dendritic cells in vitro. Hepatobiliary Pancreat Dis Int 2006; 3: 422-427.
11. Eichler H, Nguyen XD, Roelen D, Celluzzi CM, McKenna D, Pamphilon D, et al. Multicenter study on in vitro characterization of dendritic cells. Cyotherapy 2008; 1: 21-29
12. Castellano G, Woltman AM, Schlagwein N, Xu W, Schena FP, Daha MR, et al. Immune modulation of human dendritic cells by complement. Eur J Immunol 2007; 10: 2803-2811
13. Jarnjak-Jankovic S, Saeboe-Larssen S, Kvalheim G, Gaudernack G. MRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell lined-derived mRNA. Cytotherapy 2007; 6: 587-592
14. Jia Z, Liang J, Li HW, Zhang HC. A randomized trial concerning the effects of the different stimulating factors on the immature dendritic cells. J China Med Univ (Chin) 2008; 2: 211-213
15. Fu YQ, Zhang ZY, Li XS, Liu YA. Phenotype and immune activity of dendritic cells under interleukin-18 intervention. Chin J Pathophysiol (Chin) 2008; 7: 1414-1417
16. Liu C, Sun ZQ, Chen JJ, Su G, Shi JW, Liu JP, et al. Phenotype and function of murine myeloid dendritic cells loaded with trophoblastic cell antigen. Immunol J 2008; 1: 19-22.
17. + natural regulatotory T cells preferentially from aggregrates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 2008; 29: 10113-10118.
18. Koubek K. Human leukocyte differentiation antigens and CD classification. Vnitr Lek 2008; 4: 402-409.
19. Shi FF, Li SY. Experimental study on effect of recombinant human growth hormone combined with chemotherapy on stomach neoplasms implanted in nude mice. Chin Clin Oncol (Chin) 2006; 6: 443-447.
20. Zhao X, Teng LZ, Wang ZG, Xin T, Luo J, Liu Y. Proliferation activity of meningeoma and the expression of growth hormone receptor. Chin J Nerv Ment Dis (Chin) 2006; 2: 162-164.
21. Wu JZ, Tang JA, Li HX. Effect of recombinant human growth hormone on the growth of rectal cancer in SRCA. China Trop Med (Chin) 2007; 6: 870-871.
22. Liu JP, Chen T, Ling YB, Chen XX, Ou QJ. Effect of recombinant human growth hormone on growth of human Bel-7402 hepatic carcinoma xenografts in nude mice. Chin J Cancer (Chin) 2006; 3: 292-296.
23. Kadowaki N. Dendritic cells: a conductor of T cell differentiation. Allergol Int 2007; 3: 193-199.
24. + T cells by bone marrow-derived cells. Immunology 2009; 1: 50-61
25. Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 2002; 5: 623-646.
26. Parkinson C, Trainer PJ. The place of pegvisomant in the management of acromegaly. Endocrinologist 2003; 5: 408-416.
27. Jehle S, Reyes CM, Sundeen RE, Freda PU. Alternate-day administration of pegvisomant maintains normal serum insulin-like growth factor-I levels in patients with acromegaly. J Clin Endocrinol Metab 2005; 3: 1588-1593.
28. Feenstra J, de Herder WW, ten Have SMTH, van den Beld AW, Feelders RA, Janssen JAMJL, et al. Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly. Lancet 2005; 9471: 1644-1646.
29. Jorgensen JO, Feldt-Rasmussen U, Frystyk J, Chen JW, Kristensen LO, Hagen C, et al. Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist. J Clin Endocrinol Metab 2005; 10: 5627-5631
30. Ross RJ, Leung KC, Maamra M, Bennett W, Doyle N, Waters MJ, et al. Binding and functional studieswith the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinol Metab 2001; 4: 1716-1723.